Home

The International Society for Evidence-Based Neonatology (EBNEO) 

Mission

EBNEO is an international non-profit promoting evidence-based neonatal practice


Spread Knowledge

 

Staying up-to-date with literature is hard.

We support your evidence-based practice through literature curation and dissemination.


Build Community

 

"Technology is best when it brings people together."

We use modern media to connect the global neonatal community.

Alerts

EBNEO Commentary: Umbilical cord milking in nonvigorous infants: a cluster-randomized crossover trial

Does umbilical cord milking reduce NICU admission in non-vigorous neonates? Find out more in the EBNEO Commentary on the Umbilical cord milking in nonvigorous infants: a cluster-randomized crossover trial.

0 comments

EBNEO Commentary: Need to further study levetiracetam as first-line drug for neonatal convulsions

Need to further study levetiracetam as first-line drug for neonatal convulsions EBNEO Review on the levetiracetam as first-line drug for neonatal convulsions – a topic of intense interest, read more here!

0 comments

EBNEO Commentary: Hydrocortisone to Improve Survival without Bronchopulmonary Dysplasia

Hydrocortisone to Improve Survival without Bronchopulmonary Dysplasia EBNEO Review on the recent NEJM publication on hydrocortisone to improve survival without BPD – what do we do now? Learn more here!

0 comments

Reviews

EBNEO Commentary: Umbilical cord milking in nonvigorous infants: a cluster-randomized crossover trial

Does umbilical cord milking reduce NICU admission in non-vigorous neonates? Find out more in the EBNEO Commentary on the Umbilical cord milking in nonvigorous infants: a cluster-randomized crossover trial.

0 comments

EBNEO Commentary: Need to further study levetiracetam as first-line drug for neonatal convulsions

Need to further study levetiracetam as first-line drug for neonatal convulsions EBNEO Review on the levetiracetam as first-line drug for neonatal convulsions – a topic of intense interest, read more here!

0 comments

EBNEO Commentary: Hydrocortisone to Improve Survival without Bronchopulmonary Dysplasia

Hydrocortisone to Improve Survival without Bronchopulmonary Dysplasia EBNEO Review on the recent NEJM publication on hydrocortisone to improve survival without BPD – what do we do now? Learn more here!

0 comments

Registration

Registration allows you to log in and post comments under your username and receive our monthly newsletters summarizing our latest curated literature findings

Contact us

International Society for Evidence-Based Neonatology

LOCATION
c/o Department of Neonatal Medicine Sachs’ Children and Youth Hospital SE-118 83 Stockholm Sweden
Email
info@ebneo.org

Leave a comment

    css.php